α(1A)-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC

British Journal of Pharmacology

Volumn 123, Issue 2, 1998, Pages 317-325

  Burt, Richard P ^a   Chapple, Christopher R ^b   Marshall, Ian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

1 adrenoceptors; Calphostin C; Nifedipine; Noradrenaline; Protein kinase C; R 59022; Rat prostatic vas deferens; Ryanodine

Indexed keywords

5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 6 [2 [4 [(4 FLUOROPHENYL)PHENYLMETHYLENE] 1 PIPERIDYL]ETHYL] 7 METHYL 5H THIAZOLO[3,2 A]PYRIMIDIN 5 ONE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1A ADRENERGIC RECEPTOR; CALCIUM ION; CALPHOSTIN C; CYCLOPIAZONIC ACID; DIACYLGLYCEROL; NIFEDIPINE; NORADRENALIN; PHORBOL DIBUTYRATE; PRAZOSIN; PROTEIN KINASE C; RECEPTOR SUBTYPE; RYANODINE; URAPIDIL; ADRENERGIC RECEPTOR ALPHA(1A); ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR CALCIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SPIKE; TEMPERATURE; VAS DEFERENS; ANIMAL; DRUG EFFECT; IN VITRO STUDY; KINETICS; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; PROSTATE; SMOOTH MUSCLE; SPRAGUE DAWLEY RAT; STIMULATION; ULTRASTRUCTURE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CALCIUM; DIGLYCERIDES; KINETICS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NOREPINEPHRINE; PHORBOL 12,13-DIBUTYRATE; PRAZOSIN; PROSTATE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RYANODINE; STIMULATION, CHEMICAL; VAS DEFERENS;

EID: 0031594382     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701588     Document Type: Article

References (44)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br. J. Pharmacol., 109, 80-87.
2. ARUNLAKSHANA, O. & SCHILD, H.O. (1995). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-52.
3. BERRIDGE, M.J. (1993). Inositol triphosphate and calcium signalling. Nature, 361, 315-325.
4. BISHOP, W.R. & BELL, R.W. (1986). Attenuation of sn-1,2-diacylglycerol second messenger: metabolism of exogenous diacylglycerols by human platelets. J. Biol. Chem., 261, 12513-12519.
5. BRUNS, R.F., MILLER, F.D., MERRIMAN, R.L., HOWBERT, J.J., HEATH, W.F., KOBAYASHI, E. & TAKAHASHI, I. (1991). Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun., 176, 288-293.
6. 1B-adrenoceptor mediating contraction of the rat spleen. Br. J. Pharmacol., 115, 467-475.
7. 1B-adrenoceptor mediated contraction to phenylephrine in the rat spleen. Br. J. Pharmacol., 116, 2327-2333.
8. 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens. Br. J. Pharmacol., 117, 224-230.
9. BYLUND, D.B., EIKENBERG, D.C., HIEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLO, R.R. & TRENDELENBURG, U. (1994). IV. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev., 46, 121-136.
10. CASTAGNA, M., TAKAI, Y., KAIBUCHI, K., SANO, K., KIKKAWA, U. & NISHIZUKA, Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor promoting phorbol esters. J. Biol. Chem., 257, 7847-7851.
11. CLAPPER, D.L., WALSETH, T.F., DARGIE, P.J. & LEE, H.C. (1987). Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes desensitized to inositol trisphophate. J. Biol. Chem., 262, 9561-9568.
12. DE CHAFFOY DE COURCELLES, D., ROEVENS, P. & VAN BELLE, H. (1985). R 59022, a diacyl glycerol kinase inhibitor. J. Biol. Chem., 260, 15762-15770.
13. 2+-pump inhibitor of rat aortic muscle. Acta Pharmacol. Sin., 12, 53-58.
14. 2+-release channels. Trends Pharmacol. Sci., 15, 145-149.
15. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol. Sci., 15, 77-83.
16. 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol. Pharmacol., 49, 209-215.
17. 1-Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci., 15, 167-170.
18. 1-adrenoceptor classification. Br. J. Pharmacol., 121, 1127-1135.
19. 2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science (Wash. DC), 253, 1143-1146.
20. 2+ release mechanism gated by the novel pyridine nucleotide, NAADP. Trends Pharmacol. Sci., 18, 108-110.
21. HALLER, H., SMALLWOOD, J.I. & RASMUSSEN, H. (1990). Protein kinase C translocation in intact vasculature smooth muscle strips. Biochem. J., 270, 375-381.
22. 1-adrenoceptors: consensus update. Pharmacol. Rev., 47, 267-270.
23. KANOH, H., SAKANE, F., SHIN-ICHI, I. & WADA, I. (1993). Diacylglycerol kinase and phosphatidic acid phosphatase-enzymes metabolizing lipid second messengers. Cell Signalling, 5, 495-503.
24. KOBAYASHI, E., NAKANO, H., MORIMOTO, M. & TAMAOKI, T. (1989). Calphostin C (UCN-1028C), A novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 159, 548-553.
25. 2+-free medium. Br. J. Pharmacol., 81, 317-326.
26. LEE, M.W. & SEVERSON, D.L. (1994). Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am. J. Physiol., 267, C659-678.
27. 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053. Br. J. Pharmacol., 119, 407-415.
28. MCGRATH, J.C. (1982). Evidence for more than one type of post-junctional α-adrenoceptor. Biochem. Pharmacol., 31, 467-484.
29. 1-Adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol., 34, 117-133.
30. 1-adrenoceptors in vascular smooth muscle. Br.J. Pharmacol., 99, 197-201.
31. 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br. J. Pharmacol., 107, 697-704.
32. 2+ release from intracellular membrane systems. Mol. Pharmacol., 36, 673-680.
33. PUTNEY, J.W., JR. (1986). A model for receptor-regulated calcium entry. Cell Calcium, 7, 1-12.
34. PUTNEY, J.W., JR. (1990). Capacitative calcium entry revisited. Cell Calcium, 11, 611-624.
35. 1, γ, δ and ε by phorbol esters of different biological activities. FEBS Letters, 288, 5-9.
36. 1-adrenoceptor-mediated excitation-contraction coupling in isolated rat portal vein: comparison with depolarization-mediated excitation-contraction coupling. J. Cardiovasc. Pharmacol., 21, 739-748.
37. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem., 264, 17816.
38. SEVERSON, D.L. & HEE-CHEONG, M. (1986). Diacylglycerol lipase and kinase activities in rabbit aorta and coronary microvessels. Biochem. Cell Biol., 64, 976-983.
39. SORRENTINO, V. & VOLPE, P. (1993). Ryanodine receptors: how many and why? Trends Pharmacol. Sci., 14, 98-103.
40. 1-adrenoceptors mediating contraction of rat small mesenteric artery are different from those mediating pressor responses in rat perfused mesentery. Br. J. Pharmacol., 119, 27P.
41. 2+ release channels: Does diversity in form equal diversity in function? Physiol. Rev., 76, 1027-1071.
42. VESPERINAS, G., FEDDERSEN, M., LEWIN, J. & HUIDOBRO-TORO, J.P. (1989). The use of ryanodine and calciun channel blockers to characterize intra- and extracellular calcium pools mobilized by noradrenaline in the rat vas deferens. Eur. J. Pharmacol., 165, 309-313.
43. YANG, S.-G., SAIFEDDINE, M., CHUANG, M., SEVERSON, D.L. & HOLLENBERG, M.D. (1991). Diacylglycerol lipase and the contractile action of epidermal growth factor-urogastrone. Evidence for distinct signal pathways in a single strip of gastric smooth muscle. Eur. J. Pharmacol., 207, 225-230.
44. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev., 49, 1-51.